Obalon Therapeutics Inc  (OBLN) - NASDAQGM

  Revenue / EPS Summary *  
 
 Fiscal Quarter 2020
(Fiscal Year)
2019
(Fiscal Year)
2018
(Fiscal Year)
March      
   Revenue $780,000 $1,775(t) $1,346(t)
   EPS -0.68 (3/31/2020) -3.59 (3/31/2019) -7.1 (3/31/2018)
   Dividends N/A N/A N/A
June      
   Revenue   $386,000 $2,732(t)
   EPS   -2.41 (6/30/2019) -5.8 (6/30/2018)
   Dividends   N/A N/A
September      
   Revenue   $333,000 $2,987(t)
   EPS   0.93 (9/30/2019) -3.15 (9/30/2018)
   Dividends   N/A N/A
December  (FYE)      
   Revenue   $787,000 $2,036(t)
   EPS   0.04 (12/31/2019) -3.59 (12/31/2018)
   Dividends   N/A N/A
Totals      
   Revenue $780,000 $3,281(t) $9,101(t)
   EPS -0.68 -5.03 -19.64
   Dividends N/A N/A N/A
   Previous 3 Years
 
 
©2020, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.